dihydroxyphenylalanine has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dietemann, S | 1 |
| Debry, C | 1 |
| Onea, A | 1 |
| Namer, IJ | 1 |
| Imperiale, A | 1 |
1 other study available for dihydroxyphenylalanine and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Epiglottic Squamous Cell Carcinoma Showing Unexpected 18F-FDOPA Uptake on PET/CT Investigation.
Topics: Carcinoma, Squamous Cell; Dihydroxyphenylalanine; Epiglottis; Head and Neck Neoplasms; Humans; Multi | 2015 |